Trial intelligence / Profile preview

Rocaltrol for treatment of albuminuria in patients with diabetic nephropathy

IRCT2015110624903N1Phase 4Completed

Sponsor
Arak University of Medical Sciences
Start
Jun 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of calcitriol in diabetic glomerulosclerosis and albuminuria, sponsored by Arak University of Medical Sciences. Primary endpoint: Change in albuminuria. Started Jun 2015; status: completed.

02

Drugs

calcitriol
03

Conditions

diabetic glomerulosclerosisalbuminuria

Beyond the preview

Go deeper on IRCT2015110624903N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015110624903N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call